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Solitary fibrous tumor (SFT) is a rare spindle cell neoplasm, usually occurring in the pleura. Pararenal SFT, mimicking
an adrenal gland or renal tumor, as here described, is extremely rare. We report a case of a right suprarenal SFT,
incidentally discovered by abdominal ultrasound in a 54-year-old woman carrying a point neurofibromatosis 1 (NF1)
gene mutation. Preoperative diagnostic work-up was ineffective in evaluating its origin, and an open radical right
nephrectomy was therefore undertaken. Immunohistochemical assay showed a positivity for CD34, CD99 and Bcl-2,
so suggesting a diagnosis of SFT. According to our knowledge, the association between this type of tumor and NF1
gene mutation has never been described. In cases of pararenal tumors, a more detailed preoperative diagnosis
could be useful to better plan the extension of resection, allowing, in selected cases, nephron-sparing surgery. More
studies are needed to better analyze the relationship between NF1 gene mutation and SFT.
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Neurofibromatosis gene mutationBackground
Solitary fibrous tumor (SFT) is a rare spindle cell neo-
plasm, firstly described in the1930s [1]. Prognosis seems to
be favorable, but large series with long-term follow-up are
still lacking. This kind of tumor, usually occurring in the
pleura, the so called ‘localized fibrous mesothelioma’, has
recently been described in different and multiple extra-
pleural sites including orbit, nasal cavity, breast, adrenal or
thyroid gland, liver and lung [2]. Although the retroperi-
toneum is frequently involved, according to a computed
search of the medical literature, only 39 cases of renal or
pararenal SFT have been reported. Tumor size ranged
from 2 to 25 cm, and nephrectomy was the standard treat-
ment. The origin of these neoplasms is still controversial
[3,4]. They are considered as slow-growing tumors with a
favorable prognosis, although malignant cases, showing
locoregional recurrence or distant metastases, have been* Correspondence: giovanni.conzo@unina2.it
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reproduction in any medium, provided the orreported. Neurofibromatosis type 1 (von Recklinghausen’s
disease-NF1) is caused by an alteration of the NF1 gene, a
tumor suppressor located on the long arm of chromosome
17 (17q11.2) [5]. Loss of the gene function, due to a point
mutation, leads to an increase in cell proliferation and to
development of tumors [5].
We describe a right suprarenal SFT in a female patient
carrying a NF1 gene mutation. Preoperative diagnostic
work-up was unable to determine its primal tissue, and
therefore an open radical right nephrectomy was per-
formed. Only the immunohistochemical assay allowed a
correct pathological diagnosis. To better evaluate the
role of radical nephrectomy, in a case of pararenal tumor
with no clear signs of renal infiltration, more detailed
therapeutic guidelines could be useful to establish the
recommended extension of resection. According to our
literature search, this is the first case in which SFT was
associated to a NF1 gene mutation.Case presentation
In July 2012, a 52-year-old woman was referred to our
observation for the presence of a solid mass in her rightLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Computerized tomographic scan depicting large superior pole mass of the right kidney.
Figure 2 The tumor showed an admixture of irregularly
distributed highly cellular and hypocellular zones, composed of
spindled cells with vesicular nuclei, which surrounded thin- and
thick-walled vessels with a characteristic ‘stag
horn’ appearance.
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hepatitis B virus infection. Computed tomography scan
showed a well-delineated, encapsulated tumor arising
from the upper pole of the right kidney and measuring
96 × 63 mm, contrast-enhanced and with no evidence of
vessel infiltration (Figure 1). The ipsilateral adrenal gland
was not clearly distinguishable from the neoplasm, and
its adrenal origin was apparent. Magnetic resonance
imaging (MRI) scan showed a mass of low intensity on
T1-weighted images and of irregular high intensity on
T2-weighed images. Neither renal vein nor inferior vena
cava thrombosis were present, and suspected enlarged
lymph nodes were also not identified. Due to the pres-
ence of a daughter with a previous diagnosis of NF1
gene mutation, and the presence of small neurofibromas
over the patient’s body, a genetic test for NF1 using
reverse transcription (RT)-PCR and high throughput-
denaturing high performance liquid chromatography (HT-
DHPLC) was performed, confirming the diagnosis of von
Recklinghausen’s disease. Considering that a pheochromo-
cytoma (PCC) has been identified in 0.1 to 5.7% of pa-
tients with von Recklinghausen’s disease, a PCC was
considered in the differential diagnosis [6]. The absence of
clinical signs and of arterial pressure lability, associated
with a normal level of urinary metanephrine concentra-
tions and the absence of pathological uptake following
MIBG (meta iodo benzyl guanidine) scintigraphy, allowed
the exclusion of a PCC neoplasm. Since a diagnosis ofsuspected renal or adrenal gland mass was suspected, the
patient underwent an explorative laparotomy. During the
procedure, a large neoplasm, strongly adherent to the
upper renal pole and to the ipsilateral suprarenal space,
was observed and, presuming a renal cell carcinoma, we
undertook a surgical resection including a radical right
nephrectomy. No macroscopic enlarged lymph nodes
were observed. The postoperative course was uneventful
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Diagnostic work-up was negative during the eight-month
follow-up. The gross specimen included: right kidney,Figure 3 A panoramic view of the solitary fibrous tumor. (a) note the
horn’ vessels (H&E, x100); (b) The tumor cells surround a vascular compone
show a widespread immunoreactivity for CD34 (immunoperoxidase stain fo
(immunoperoxidase stain for CD99, x200); (e) The tumor cells exhibit a diffu
tumor cells show a proliferation index to a maximum of about 10% of neoureter, adrenal gland, perinephric tissue and a mass meas-
uring 90 × 60 × 40 mm in overall dimensions. At micros-
copy, the tumor showed an admixture of irregularlycellular proliferation of spindled cells, the dense collagen and the ‘stag
nt with a ‘stag horn’ appearance ((b) H&E, x150); (c) The tumor cells
r CD34, x200); (d) The tumor cells exhibit a strong positivity for CD99
se staining for bcl-2 (immunoperoxidase stain for bcl-2, x200); (f) The
plastic cells (immunoperoxidase stain for Ki67/MIB-1, x150).
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posed of spindled cells with vesicular nuclei, which sur-
rounded thin- and thick-walled vessels with a characteristic
‘stag horn’ appearance. A prominent hyalinized collagen
was present (Figure 2). Most tumor cells expressed CD34,
CD99, and bcl-2, whereas cytokeratin, CD117 (c-Kit), S-
100 protein and EMA were negative. The Ki-67 (MIB-1)
staining, a marker of cellular proliferation, was irregularly
expressed, exhibiting positivity in up to about 10% of neo-
plastic cells. Based on morphological features and immu-
nohistochemical profile, a diagnosis of a solitary fibrous
tumor was made (Figure 3).
Conclusions
In most cases of SFT, described as renal or pararenal
tumor, it is very difficult to determine the true origin
from the renal capsule [4], the interstitial tissue, or the
peripelvic connective tissue. Therefore, in planning a
therapeutic protocol, extension of resection may be
controversial and ‘classical’ nephrectomy remains the
most common treatment. In the reported case, only de-
finitive pathology identified a well-encapsulated SFT
not infiltrating the kidney and the ipsilateral adrenal
gland, and radical nephrectomy could probably be con-
sidered an overtreatment. Histopathological examin-
ation, immunohistochemical and ultrastructural studies
are the cornerstone of SFT diagnosis. Morphologically,
it is characterized by spindle cell proliferation, and
about 70% of cases expresses CD 34, CD99, and Bcl-2;
only between 20 and 35% of cases are variably positive
for epithelial membrane antigen and smooth muscle
actin. Focal and limited reactivity of S-100 protein,
cytokeratins and/or desmin has also occasionally been
reported [6]. Strong CD34 reactivity is currently regarded
as characteristic, and an indispensable finding in the diag-
nosis of SFT [7].
Since these tumors typically show hemangio-
pericytomatous patterns, differential diagnosis includes
sarcomatoid renal cell carcinoma or renal adenoma and
other benign spindle cell tumors such as angiomyoli-
poma, fibroma, or fibrosarcoma [4]. In presence of a
NF1 gene mutation, neurofibroma should also be con-
sidered. SFT is a rare tumor sometimes mimicking renal
cell or adrenal gland neoplasms [8,9], and it must be
considered in cases of renal tumors comprising mesen-
chymal elements. In roughly 10 to 15% of cases, they
behave aggressively, showing local recurrence or distant
metastases [4]. According to England et al. [10], in-
creased cellularity with crowded/overlapping nuclei,
cellular pleomorphism, and a mitotic count of more
than four figures per ten high-power fields are consid-
ered criteria for malignancy. However, clinical progres-
sion of tumors with a benign appearance cannot be
predicted on histopathological basis, which can exhibitaggressive behavior, and vice versa. Therefore, all SFT
patients need to be on long-term follow-up [4,7]. Turning
to treatment, complete surgical resection is recommended
[3], but because SFTs exhibit relative chemo-radio tumor
resistance, no data are reported regarding the role of adju-
vant treatment. In case of a preoperative suspicion of a
well-encapsulated pararenal SFT, in the absence of clear
signs of locoregional infiltration, the recommended exten-
sion of resection could be controversial. We hypothesize
that, in selected cases, a nephrectomy could be avoided
with comparable outcomes [11]. The rarity of pararenal
SFT does not allow randomized prospective trials con-
cerning this issue. Preoperative diagnostic efforts must be
made to achieve detailed data about its origin in order to
plan a tailored surgery. The association of STF and the
NF1 gene mutation is intriguing. However, since NF1 gene
mutation has not been investigated systematically in STF
cases, and the available evidence in the literature data is
insufficient, it is hard to hypothesize how a gene mutation
might determine the development of a suprarenal neo-
plasm. More studies are needed to better analyze the rela-
tionships between SFT and NF1 gene mutation.
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